bevacizumab
Myriad Genetics Expands MyChoice CDx Access Through Partnerships in Europe, China
A deal with Burning Rock will allow the test to be used in trials and clinics in China, and Myriad will license its technology to French and German pathology labs.
HalioDx, FFCD Collaborate for Phase II Metastatic Colorectal Cancer Trial
HalioDx's Immunoscore test, which measures host immune response at the tumor site, will be used to select patients for the trial.